Confirming the therapeutic potential of MSCs, Pollock et al. [17] demonstrated that bone marrow MSC genetically modified to overexpress BDNF (MSC/BDNF) induced a significant increase in neurogenesis-like activity and increased life expectancy in R6/2 mice (transgenic mouse model for HD). Here, BDNF is linked to Huntington disease.